Table 1.

Cases of sporotrichosis in renal transplant recipients previously reported

Author/year	Age, years/gender	Clinical manifestation	Time after transplantation	Treatment
Gullberg et al., 1987	50/male	Cutaneous, osteoarticular, neurological	4 years	AMB-d
Agarwal et al., 1994	23/male	Urinary tract	9 months	None
Rao et al., 2002	49/female	Nasal mucosa	6 months	None
Caroti et al., 2010	59/male	Cutaneous, osteoarticular	Unknown	FLZ
Gewehr et al., 2013	48/female	Cutaneous	9 months	AMB-L, ITZ
	53/male	Cutaneous, osteoarticular	1 month	AMB-L, ITZ
Amirali et al., 2020	43/male	Cutaneous	10 years	ITZ
	56/male	Neurological, pulmonary	17 years	AMB-d; ITZ
Fichman et al., 2020	41/female	Cutaneous, oral, and nasal mucosa	Unknown	AMB-d, AMB-L, ITZ, TRB
	34/male	lymphocutaneous	Unknown	TRB+ITZ
	51/male	lymphocutaneous	Unknown	TRB
	43/male	Cutaneous, oral, and nasal mucosa, osteoarticular	Unknown	AMB-L, ITZ
	42/male	lymphocutaneous	Unknown	ITZ
	54/male	lymphocutaneous	Unknown	TRB

AMB-d = amphotericin B; AMB-L = liposomal amphotericin B; FLZ = fluconazole; ITZ = itraconazole; TRB = terbinafine.